
Our company has 18 employees, including 4 doctors, 6 masters and 2 pharmacists, with excellent R & D team, strong technical force, a dynamic management mechanism, first-class management talent and a good financing channel. Our company is perfectly capable of developing new drugs and advancing technology into economic benefits, to achieve social benefits.
Our employees have extensive experience in the synthesis of small molecule drugs and microbial fermentation. In pharmaceutical preparations, our company has developed a variety of dosage forms, including some new formulations such as liquid capsules, controlled release and targeted drug delivery systems. Our company has a wealth of export agents of registered technology, and drug product registration experience of exporting to the EU, the United States, Cuba, Brazil and India. Our company has established a comprehensive library of fermentation bacteria, with dozens of drugs bacteria fermentation species, such as erythromycin, daptomycin, Nepal, the Secretary and a full set of statins and other bacteria fermentation process.